HELIUS MEDICAL TECHNOLOGIES (HSDT)
US42328V8019 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 520K -21.21% | 787K 51.35% | 644K -18.17% | 477.36K -25.88% | 520.2K 8.97% | 910.86K 75.10% | 42.421M 4,557.25% | 65.34M 54.03% | 78.07M 19.48% | 91.125M 16.72% | 97.676M 7.19% | |
| EBITDA YoY % growth | -17.81M -30.96% | -14.504M 18.56% | -12.107M 16.53% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -18.12M -28.69% | -14.759M 18.55% | -12.269M 16.87% | -14.563M -18.69% | -14.777M -1.47% | 5.714M 138.67% | 23.711M 314.96% | 41.644M 75.63% | 55.307M 32.81% | 65.96M 19.26% | 71.064M 7.74% | |
| Operating Margin | -3,484.62% | -1,875.35% | -1,905.12% | -3,050.64% | -2,840.59% | 627.32% | 55.89% | 63.73% | 70.84% | 72.38% | 72.75% | |
| EPS YoY % growth | -6.35 98.94% | -116.00 -1,726.77% | -14.46 87.53% | -5.75 60.22% | -2.55 55.67% | -2.33 8.80% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.96 34.78% | -0.94 69.53% | -0.54 15.53% | -0.53 46.42% | -0.53 44.68% |
| Revenue Q2Q % growth | 102K -23.88% | 102K -24.44% | 112.2K -38.35% | 142.8K 180.00% | 163.2K 60.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.591M -59.90% | -3.759M -10.03% | -3.605M -10.23% | -3.616M 11.16% | -3.797M -5.74% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.99 81.97% | -1.08 | 0.09 | 8.44% |
| Q2 2024 Q2Q % growth | -0.64 78.67% | -0.51 | -0.13 | -25.49% |
| Q1 2024 Q2Q % growth | -3.08 31.56% | -3.95 | 0.87 | 21.97% |
| Q4 2023 Q2Q % growth | -1.47 82.71% | -3.85 | 2.38 | 61.81% |
| Q3 2023 Q2Q % growth | -5.49 -266.00% | -6.12 | 0.63 | 10.29% |
| Q2 2023 Q2Q % growth | -3.00 93.81% | -5.95 | 2.95 | 49.58% |
| Q1 2023 Q2Q % growth | -4.50 92.17% | -5.61 | 1.11 | 19.79% |
| Q4 2022 Q2Q % growth | -8.50 -548.85% | -6.63 | -1.87 | -28.21% |
| Q3 2022 Q2Q % growth | -1.50 7.98% | -10.71 | 9.21 | 85.99% |
| Q2 2022 Q2Q % growth | -48.50 -2,655.68% | -57.12 | 8.62 | 15.09% |
| Q1 2022 Q2Q % growth | -57.50 -3,384.85% | -57.63 | 0.13 | 0.23% |
| Q4 2021 Q2Q % growth | -1.31 88.61% | -1.18 | -0.13 | -10.72% |
| Q3 2021 Q2Q % growth | -1.63 49.27% | -1.79 | 0.16 | 8.68% |
| Q2 2021 Q2Q % growth | -1.76 57.50% | -1.65 | -0.11 | -6.84% |
| Q1 2021 Q2Q % growth | -1.65 71.11% | -1.54 | -0.11 | -7.13% |
| Q4 2020 Q2Q % growth | -11.50 -56.37% | -1.81 | -9.69 | -536.98% |
| Q3 2020 Q2Q % growth | 58.27% | -3.21 | % | |
| Q2 2020 Q2Q % growth | -1,083.20% | -4.14 | % | |
| Q1 2020 Q2Q % growth | -426.40% | -5.71 | % | |
| Q4 2019 Q2Q % growth | -0.06% | -7.35 | % | |
| Q3 2019 Q2Q % growth | -7.70 -15.79% | -7.80 | 0.10 | 1.29% |
| Q2 2019 Q2Q % growth | -0.35 98.72% | -8.03 | 7.68 | 95.64% |
| Q1 2019 Q2Q % growth | 1.75 | -9.10 | 10.85 | 119.22% |
| Q4 2018 Q2Q % growth | -7.35 | -7.32 | -0.03 | -0.43% |
| Q3 2018 Q2Q % growth | -6.65 | -8.21 | 1.56 | 19.01% |
| Q2 2018 Q2Q % growth | -27.30 | -8.21 | -19.09 | -232.48% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 51K -64.34% | 153K | -102K | -66.67% |
| Q2 2024 Q2Q % growth | 182K -28.91% | 153K | 29K | 18.95% |
| Q1 2024 Q2Q % growth | 135K 21.62% | 133.11K | 1.89K | 1.42% |
| Q4 2023 Q2Q % growth | 134K -52.48% | 251.257K | -117.257K | -46.67% |
| Q3 2023 Q2Q % growth | 143K -28.50% | 351.9K | -208.9K | -59.36% |
| Q2 2023 Q2Q % growth | 256K 113.33% | 192.097K | 63.903K | 33.27% |
| Q1 2023 Q2Q % growth | 111K -41.58% | 288.997K | -177.997K | -61.59% |
| Q4 2022 Q2Q % growth | 282K 8.46% | 264.18K | 17.82K | 6.75% |
| Q3 2022 Q2Q % growth | 200K 81.82% | 170.85K | 29.15K | 17.06% |
| Q2 2022 Q2Q % growth | 120K 71.43% | 367.2K | -247.2K | -67.32% |
| Q1 2022 Q2Q % growth | 190K 137.50% | 163.2K | 26.8K | 16.42% |
| Q4 2021 Q2Q % growth | 260K 36.84% | 102K | 158K | 154.90% |
| Q3 2021 Q2Q % growth | 110K -15.38% | 86.19K | 23.81K | 27.63% |
| Q2 2021 Q2Q % growth | 70K -46.15% | 96.9K | -26.9K | -27.76% |
| Q1 2021 Q2Q % growth | 80K -61.90% | 85.17K | -5.17K | -6.07% |
| Q4 2020 Q2Q % growth | 190K 26.67% | 193.8K | -3.8K | -1.96% |
| Q3 2020 Q2Q % growth | 130K -13.33% | 101.499K | 28.501K | 28.08% |
| Q2 2020 Q2Q % growth | 130K -75.00% | 101.499K | 28.501K | 28.08% |
| Q1 2020 Q2Q % growth | 210K -69.12% | 304.499K | -94.499K | -31.03% |
| Q4 2019 Q2Q % growth | 150K -68.75% | % | ||
| Q3 2019 Q2Q % growth | 150K | 306K | -156K | -50.98% |
| Q2 2019 Q2Q % growth | 520K | 306K | 214K | 69.93% |
| Q1 2019 Q2Q % growth | 680K | 153K | 527K | 344.44% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -2.17% | 0.35% | 0.35% |
| Revenue | 0% | -62.69% | -36.33% | -36.33% |